Pacira BioSciences, Inc.
PCRXFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Pacira BioSciences, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 17 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 12, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Legato Capital Management LLC | 2026-03-31 | 39,007 | $882K | SEC filing |
| Ameritas Advisory Services, LLC | 2026-03-31 | 2 | $45 | SEC filing |
| BESSEMER GROUP INC | 2026-03-31 | 967 | Not shown | SEC filing |
| EASTERLY INVESTMENT PARTNERS LLC | 2026-03-31 | 334,854 | $7.66M | SEC filing |
| Invesco Ltd. | 2026-03-31 | 237,580 | $5.37M | SEC filing |
| Doma Perpetual Capital Management LLC | 2026-03-31 | 2,777,794 | $62.8M | SEC filing |
| Cornerstone Planning Group LLC | 2026-03-31 | 18 | $447 | SEC filing |
| Police & Firemen's Retirement System of New Jersey | 2026-03-31 | 10,513 | $238K | SEC filing |
| GF FUND MANAGEMENT CO. LTD. | 2026-03-31 | 967 | $21.9K | SEC filing |
| VIRTUS ADVISERS, LLC | 2026-03-31 | 6,765 | $153K | SEC filing |
| Squarepoint Ops LLC | 2026-03-31 | 32,685 | $739K | SEC filing |
| Cetera Investment Advisers | 2026-03-31 | 16,270 | $368K | SEC filing |
| Universal- Beteiligungs- und Servicegesellschaft mbH | 2026-03-31 | 80,017 | $1.81M | SEC filing |
| Annis Gardner Whiting Capital Advisors, LLC | 2026-03-31 | 4 | $91 | SEC filing |
| 1620 INVESTMENT ADVISORS, INC. | 2026-03-31 | 977 | $22.1K | SEC filing |
| PNC FINANCIAL SERVICES GROUP, INC. | 2026-03-31 | 3,751 | $84.8K | SEC filing |
| Essential Partners LLC | 2026-03-31 | 134 | $3.03K | SEC filing |
| Steward Partners Investment Advisory, LLC | 2026-03-31 | 30,419 | $687K | SEC filing |
| AMERICAN CENTURY COMPANIES INC | 2026-03-31 | 837,563 | $18.9M | SEC filing |
| Banco Santander, S.A. | 2026-03-31 | 166,000 | $3.75M | SEC filing |
- Each value is checked against Pacira BioSciences, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 1 row: the filed value is about 1,000 times too small for the share count at Pacira BioSciences, Inc.'s share price.
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Pacira BioSciences, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-04-23 · Cross Shawn: Larger than 72 of the 78 other insider sales of Common Stock on file. SEC filing
- 2026-02-02 · WILLIAMS KRISTEN: Larger than 73 of the 78 other insider sales of Common Stock on file. SEC filing
- 2025-12-09 · Cross Shawn: Larger than 76 of the 78 other insider sales of Common Stock on file. SEC filing
- 2025-11-10 · Cross Shawn: Larger than 71 of the 78 other insider sales of Common Stock on file. SEC filing
- 2025-06-04 · WILLIAMS KRISTEN: Larger than 74 of the 78 other insider sales of Common Stock on file. SEC filing
- 2024-03-08 · PACE GARY W: Larger than all 78 other insider sales of Common Stock on file. SEC filing
- 2024-03-07 · PACE GARY W: Larger than 77 of the 78 other insider sales of Common Stock on file. SEC filing
- 2023-06-08 · Kronenfeld Mark A.: Larger than 75 of the 78 other insider sales of Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-11 | RIKER LAUREN · Senior Vice President, Finance | Common Stock | S — Open market or private sale | −6,115 | 23.50 | SEC filing |
| 2026-06-04 | WILLIAMS KRISTEN · Chief Administrative Officer | Common Stock | S — Open market or private sale | −10,259 | 22.27 | SEC filing |
| 2026-04-23 | Cross Shawn · Chief Financial Officer | Common Stock | S — Open market or private sale | −12,941 | 25.16 | SEC filing |
| 2026-04-22 | Cross Shawn · Chief Financial Officer | Common Stock | S — Open market or private sale | −1,500 | 25.01 | SEC filing |
| 2026-04-21 | Cross Shawn · Chief Financial Officer | Common Stock | S — Open market or private sale | −2,845 | 25.01 | SEC filing |
| 2026-04-20 | Cross Shawn · Chief Financial Officer | Common Stock | S — Open market or private sale | −7,714 | 25.14 | SEC filing |
| 2026-03-17 | SLONIN JONATHAN · Chief Medical Officer | Common Stock | S — Open market or private sale | −3,261 | 22.82 | SEC filing |
| 2026-03-17 | Froimson Mark · Director | Common Stock | S — Open market or private sale | −500 | 21.81 | SEC filing |
Showing 8 of 16 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-10 | Hirawat Samit · Director | Common Stock | A — Grant, award, or other acquisition | +6,405 | SEC filing |
| 2026-06-10 | Froimson Mark · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +10,891 | SEC filing |
| 2026-06-10 | Brege Laura · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +10,891 | SEC filing |
| 2026-06-10 | YANG MICHAEL J. · Director | Common Stock | A — Grant, award, or other acquisition | +6,405 | SEC filing |
| 2026-06-10 | CHRISTIE CHRISTOPHER · Director | Common Stock | A — Grant, award, or other acquisition | +6,405 | SEC filing |
| 2026-06-10 | CHRISTIE CHRISTOPHER · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +10,891 | SEC filing |
| 2026-06-10 | BIGAL MARCELO · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +10,891 | SEC filing |
| 2026-06-10 | Brege Laura · Director | Common Stock | A — Grant, award, or other acquisition | +6,405 | SEC filing |
Showing 8 of 30 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.